Athersys, Inc. Presents New Data Demonstrating Potential Benefits From MultiStem After Spinal Cord Injury  
10/16/2012 10:00:31 AM

CLEVELAND, Oct. 15, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) presented new research results this morning at the Society for Neuroscience annual meeting in New Orleans, demonstrating the potential for MultiStem®, a novel stem cell therapy being developed by Athersys, to treat spinal cord injury (SCI).